Global AI Medical Imaging Software for Lung Diseases Market 2025 by Company, Regions, Type and Application, Forecast to 2031
According to our latest research, the global AI Medical Imaging Software for Lung Diseases market size will reach USD million in 2031, growing at a CAGR of %over the analysis period.
AI medical imaging software for lung diseases leverages artificial intelligence to automatically analyze medical images such as CT scans and X-rays, assisting physicians in detecting and diagnosing various lung conditions, including lung nodules, pneumonia, and chronic obstructive pulmonary disease (COPD). The software utilizes deep learning algorithms to identify abnormalities and offers precise localization and classification suggestions, enhancing diagnostic accuracy and efficiency. It also supports early disease detection and aids in clinical decision-making, reducing the workload on healthcare professionals.
This report is a detailed and comprehensive analysis for global AI Medical Imaging Software for Lung Diseases market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global AI Medical Imaging Software for Lung Diseases market size and forecasts, in consumption value ($ Million), 2020-2031
Global AI Medical Imaging Software for Lung Diseases market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global AI Medical Imaging Software for Lung Diseases market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global AI Medical Imaging Software for Lung Diseases market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for AI Medical Imaging Software for Lung Diseases
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global AI Medical Imaging Software for Lung Diseases market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Siemens, Riverain Technologies, Deepwise, Shukun Technology, Infervision Medical, United-Imaging, Yizhun Intelligent, VoxelCloud, Fosun Aitrox, Huiying Medical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
AI Medical Imaging Software for Lung Diseases market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe AI Medical Imaging Software for Lung Diseases product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of AI Medical Imaging Software for Lung Diseases, with revenue, gross margin, and global market share of AI Medical Imaging Software for Lung Diseases from 2020 to 2025.
Chapter 3, the AI Medical Imaging Software for Lung Diseases competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and AI Medical Imaging Software for Lung Diseases market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of AI Medical Imaging Software for Lung Diseases.
Chapter 13, to describe AI Medical Imaging Software for Lung Diseases research findings and conclusion.
AI medical imaging software for lung diseases leverages artificial intelligence to automatically analyze medical images such as CT scans and X-rays, assisting physicians in detecting and diagnosing various lung conditions, including lung nodules, pneumonia, and chronic obstructive pulmonary disease (COPD). The software utilizes deep learning algorithms to identify abnormalities and offers precise localization and classification suggestions, enhancing diagnostic accuracy and efficiency. It also supports early disease detection and aids in clinical decision-making, reducing the workload on healthcare professionals.
This report is a detailed and comprehensive analysis for global AI Medical Imaging Software for Lung Diseases market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global AI Medical Imaging Software for Lung Diseases market size and forecasts, in consumption value ($ Million), 2020-2031
Global AI Medical Imaging Software for Lung Diseases market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global AI Medical Imaging Software for Lung Diseases market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global AI Medical Imaging Software for Lung Diseases market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for AI Medical Imaging Software for Lung Diseases
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global AI Medical Imaging Software for Lung Diseases market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Siemens, Riverain Technologies, Deepwise, Shukun Technology, Infervision Medical, United-Imaging, Yizhun Intelligent, VoxelCloud, Fosun Aitrox, Huiying Medical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
AI Medical Imaging Software for Lung Diseases market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Pulmonary Nodules
- Pneumonia
- Other
- Hospital
- Clinic
- Siemens
- Riverain Technologies
- Deepwise
- Shukun Technology
- Infervision Medical
- United-Imaging
- Yizhun Intelligent
- VoxelCloud
- Fosun Aitrox
- Huiying Medical
- BioMind
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe AI Medical Imaging Software for Lung Diseases product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of AI Medical Imaging Software for Lung Diseases, with revenue, gross margin, and global market share of AI Medical Imaging Software for Lung Diseases from 2020 to 2025.
Chapter 3, the AI Medical Imaging Software for Lung Diseases competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and AI Medical Imaging Software for Lung Diseases market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of AI Medical Imaging Software for Lung Diseases.
Chapter 13, to describe AI Medical Imaging Software for Lung Diseases research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of AI Medical Imaging Software for Lung Diseases by Type
1.3.1 Overview: Global AI Medical Imaging Software for Lung Diseases Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global AI Medical Imaging Software for Lung Diseases Consumption Value Market Share by Type in 2024
1.3.3 Pulmonary Nodules
1.3.4 Pneumonia
1.3.5 Other
1.4 Global AI Medical Imaging Software for Lung Diseases Market by Application
1.4.1 Overview: Global AI Medical Imaging Software for Lung Diseases Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospital
1.4.3 Clinic
1.5 Global AI Medical Imaging Software for Lung Diseases Market Size & Forecast
1.6 Global AI Medical Imaging Software for Lung Diseases Market Size and Forecast by Region
1.6.1 Global AI Medical Imaging Software for Lung Diseases Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global AI Medical Imaging Software for Lung Diseases Market Size by Region, (2020-2031)
1.6.3 North America AI Medical Imaging Software for Lung Diseases Market Size and Prospect (2020-2031)
1.6.4 Europe AI Medical Imaging Software for Lung Diseases Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific AI Medical Imaging Software for Lung Diseases Market Size and Prospect (2020-2031)
1.6.6 South America AI Medical Imaging Software for Lung Diseases Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa AI Medical Imaging Software for Lung Diseases Market Size and Prospect (2020-2031)
2 COMPANY PROFILES
2.1 Siemens
2.1.1 Siemens Details
2.1.2 Siemens Major Business
2.1.3 Siemens AI Medical Imaging Software for Lung Diseases Product and Solutions
2.1.4 Siemens AI Medical Imaging Software for Lung Diseases Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Siemens Recent Developments and Future Plans
2.2 Riverain Technologies
2.2.1 Riverain Technologies Details
2.2.2 Riverain Technologies Major Business
2.2.3 Riverain Technologies AI Medical Imaging Software for Lung Diseases Product and Solutions
2.2.4 Riverain Technologies AI Medical Imaging Software for Lung Diseases Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Riverain Technologies Recent Developments and Future Plans
2.3 Deepwise
2.3.1 Deepwise Details
2.3.2 Deepwise Major Business
2.3.3 Deepwise AI Medical Imaging Software for Lung Diseases Product and Solutions
2.3.4 Deepwise AI Medical Imaging Software for Lung Diseases Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Deepwise Recent Developments and Future Plans
2.4 Shukun Technology
2.4.1 Shukun Technology Details
2.4.2 Shukun Technology Major Business
2.4.3 Shukun Technology AI Medical Imaging Software for Lung Diseases Product and Solutions
2.4.4 Shukun Technology AI Medical Imaging Software for Lung Diseases Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Shukun Technology Recent Developments and Future Plans
2.5 Infervision Medical
2.5.1 Infervision Medical Details
2.5.2 Infervision Medical Major Business
2.5.3 Infervision Medical AI Medical Imaging Software for Lung Diseases Product and Solutions
2.5.4 Infervision Medical AI Medical Imaging Software for Lung Diseases Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Infervision Medical Recent Developments and Future Plans
2.6 United-Imaging
2.6.1 United-Imaging Details
2.6.2 United-Imaging Major Business
2.6.3 United-Imaging AI Medical Imaging Software for Lung Diseases Product and Solutions
2.6.4 United-Imaging AI Medical Imaging Software for Lung Diseases Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 United-Imaging Recent Developments and Future Plans
2.7 Yizhun Intelligent
2.7.1 Yizhun Intelligent Details
2.7.2 Yizhun Intelligent Major Business
2.7.3 Yizhun Intelligent AI Medical Imaging Software for Lung Diseases Product and Solutions
2.7.4 Yizhun Intelligent AI Medical Imaging Software for Lung Diseases Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Yizhun Intelligent Recent Developments and Future Plans
2.8 VoxelCloud
2.8.1 VoxelCloud Details
2.8.2 VoxelCloud Major Business
2.8.3 VoxelCloud AI Medical Imaging Software for Lung Diseases Product and Solutions
2.8.4 VoxelCloud AI Medical Imaging Software for Lung Diseases Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 VoxelCloud Recent Developments and Future Plans
2.9 Fosun Aitrox
2.9.1 Fosun Aitrox Details
2.9.2 Fosun Aitrox Major Business
2.9.3 Fosun Aitrox AI Medical Imaging Software for Lung Diseases Product and Solutions
2.9.4 Fosun Aitrox AI Medical Imaging Software for Lung Diseases Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Fosun Aitrox Recent Developments and Future Plans
2.10 Huiying Medical
2.10.1 Huiying Medical Details
2.10.2 Huiying Medical Major Business
2.10.3 Huiying Medical AI Medical Imaging Software for Lung Diseases Product and Solutions
2.10.4 Huiying Medical AI Medical Imaging Software for Lung Diseases Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Huiying Medical Recent Developments and Future Plans
2.11 BioMind
2.11.1 BioMind Details
2.11.2 BioMind Major Business
2.11.3 BioMind AI Medical Imaging Software for Lung Diseases Product and Solutions
2.11.4 BioMind AI Medical Imaging Software for Lung Diseases Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 BioMind Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global AI Medical Imaging Software for Lung Diseases Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of AI Medical Imaging Software for Lung Diseases by Company Revenue
3.2.2 Top 3 AI Medical Imaging Software for Lung Diseases Players Market Share in 2024
3.2.3 Top 6 AI Medical Imaging Software for Lung Diseases Players Market Share in 2024
3.3 AI Medical Imaging Software for Lung Diseases Market: Overall Company Footprint Analysis
3.3.1 AI Medical Imaging Software for Lung Diseases Market: Region Footprint
3.3.2 AI Medical Imaging Software for Lung Diseases Market: Company Product Type Footprint
3.3.3 AI Medical Imaging Software for Lung Diseases Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global AI Medical Imaging Software for Lung Diseases Consumption Value and Market Share by Type (2020-2025)
4.2 Global AI Medical Imaging Software for Lung Diseases Market Forecast by Type (2026-2031)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global AI Medical Imaging Software for Lung Diseases Consumption Value Market Share by Application (2020-2025)
5.2 Global AI Medical Imaging Software for Lung Diseases Market Forecast by Application (2026-2031)
6 NORTH AMERICA
6.1 North America AI Medical Imaging Software for Lung Diseases Consumption Value by Type (2020-2031)
6.2 North America AI Medical Imaging Software for Lung Diseases Market Size by Application (2020-2031)
6.3 North America AI Medical Imaging Software for Lung Diseases Market Size by Country
6.3.1 North America AI Medical Imaging Software for Lung Diseases Consumption Value by Country (2020-2031)
6.3.2 United States AI Medical Imaging Software for Lung Diseases Market Size and Forecast (2020-2031)
6.3.3 Canada AI Medical Imaging Software for Lung Diseases Market Size and Forecast (2020-2031)
6.3.4 Mexico AI Medical Imaging Software for Lung Diseases Market Size and Forecast (2020-2031)
7 EUROPE
7.1 Europe AI Medical Imaging Software for Lung Diseases Consumption Value by Type (2020-2031)
7.2 Europe AI Medical Imaging Software for Lung Diseases Consumption Value by Application (2020-2031)
7.3 Europe AI Medical Imaging Software for Lung Diseases Market Size by Country
7.3.1 Europe AI Medical Imaging Software for Lung Diseases Consumption Value by Country (2020-2031)
7.3.2 Germany AI Medical Imaging Software for Lung Diseases Market Size and Forecast (2020-2031)
7.3.3 France AI Medical Imaging Software for Lung Diseases Market Size and Forecast (2020-2031)
7.3.4 United Kingdom AI Medical Imaging Software for Lung Diseases Market Size and Forecast (2020-2031)
7.3.5 Russia AI Medical Imaging Software for Lung Diseases Market Size and Forecast (2020-2031)
7.3.6 Italy AI Medical Imaging Software for Lung Diseases Market Size and Forecast (2020-2031)
8 ASIA-PACIFIC
8.1 Asia-Pacific AI Medical Imaging Software for Lung Diseases Consumption Value by Type (2020-2031)
8.2 Asia-Pacific AI Medical Imaging Software for Lung Diseases Consumption Value by Application (2020-2031)
8.3 Asia-Pacific AI Medical Imaging Software for Lung Diseases Market Size by Region
8.3.1 Asia-Pacific AI Medical Imaging Software for Lung Diseases Consumption Value by Region (2020-2031)
8.3.2 China AI Medical Imaging Software for Lung Diseases Market Size and Forecast (2020-2031)
8.3.3 Japan AI Medical Imaging Software for Lung Diseases Market Size and Forecast (2020-2031)
8.3.4 South Korea AI Medical Imaging Software for Lung Diseases Market Size and Forecast (2020-2031)
8.3.5 India AI Medical Imaging Software for Lung Diseases Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia AI Medical Imaging Software for Lung Diseases Market Size and Forecast (2020-2031)
8.3.7 Australia AI Medical Imaging Software for Lung Diseases Market Size and Forecast (2020-2031)
9 SOUTH AMERICA
9.1 South America AI Medical Imaging Software for Lung Diseases Consumption Value by Type (2020-2031)
9.2 South America AI Medical Imaging Software for Lung Diseases Consumption Value by Application (2020-2031)
9.3 South America AI Medical Imaging Software for Lung Diseases Market Size by Country
9.3.1 South America AI Medical Imaging Software for Lung Diseases Consumption Value by Country (2020-2031)
9.3.2 Brazil AI Medical Imaging Software for Lung Diseases Market Size and Forecast (2020-2031)
9.3.3 Argentina AI Medical Imaging Software for Lung Diseases Market Size and Forecast (2020-2031)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa AI Medical Imaging Software for Lung Diseases Consumption Value by Type (2020-2031)
10.2 Middle East & Africa AI Medical Imaging Software for Lung Diseases Consumption Value by Application (2020-2031)
10.3 Middle East & Africa AI Medical Imaging Software for Lung Diseases Market Size by Country
10.3.1 Middle East & Africa AI Medical Imaging Software for Lung Diseases Consumption Value by Country (2020-2031)
10.3.2 Turkey AI Medical Imaging Software for Lung Diseases Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia AI Medical Imaging Software for Lung Diseases Market Size and Forecast (2020-2031)
10.3.4 UAE AI Medical Imaging Software for Lung Diseases Market Size and Forecast (2020-2031)
11 MARKET DYNAMICS
11.1 AI Medical Imaging Software for Lung Diseases Market Drivers
11.2 AI Medical Imaging Software for Lung Diseases Market Restraints
11.3 AI Medical Imaging Software for Lung Diseases Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 AI Medical Imaging Software for Lung Diseases Industry Chain
12.2 AI Medical Imaging Software for Lung Diseases Upstream Analysis
12.3 AI Medical Imaging Software for Lung Diseases Midstream Analysis
12.4 AI Medical Imaging Software for Lung Diseases Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of AI Medical Imaging Software for Lung Diseases by Type
1.3.1 Overview: Global AI Medical Imaging Software for Lung Diseases Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global AI Medical Imaging Software for Lung Diseases Consumption Value Market Share by Type in 2024
1.3.3 Pulmonary Nodules
1.3.4 Pneumonia
1.3.5 Other
1.4 Global AI Medical Imaging Software for Lung Diseases Market by Application
1.4.1 Overview: Global AI Medical Imaging Software for Lung Diseases Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospital
1.4.3 Clinic
1.5 Global AI Medical Imaging Software for Lung Diseases Market Size & Forecast
1.6 Global AI Medical Imaging Software for Lung Diseases Market Size and Forecast by Region
1.6.1 Global AI Medical Imaging Software for Lung Diseases Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global AI Medical Imaging Software for Lung Diseases Market Size by Region, (2020-2031)
1.6.3 North America AI Medical Imaging Software for Lung Diseases Market Size and Prospect (2020-2031)
1.6.4 Europe AI Medical Imaging Software for Lung Diseases Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific AI Medical Imaging Software for Lung Diseases Market Size and Prospect (2020-2031)
1.6.6 South America AI Medical Imaging Software for Lung Diseases Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa AI Medical Imaging Software for Lung Diseases Market Size and Prospect (2020-2031)
2 COMPANY PROFILES
2.1 Siemens
2.1.1 Siemens Details
2.1.2 Siemens Major Business
2.1.3 Siemens AI Medical Imaging Software for Lung Diseases Product and Solutions
2.1.4 Siemens AI Medical Imaging Software for Lung Diseases Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Siemens Recent Developments and Future Plans
2.2 Riverain Technologies
2.2.1 Riverain Technologies Details
2.2.2 Riverain Technologies Major Business
2.2.3 Riverain Technologies AI Medical Imaging Software for Lung Diseases Product and Solutions
2.2.4 Riverain Technologies AI Medical Imaging Software for Lung Diseases Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Riverain Technologies Recent Developments and Future Plans
2.3 Deepwise
2.3.1 Deepwise Details
2.3.2 Deepwise Major Business
2.3.3 Deepwise AI Medical Imaging Software for Lung Diseases Product and Solutions
2.3.4 Deepwise AI Medical Imaging Software for Lung Diseases Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Deepwise Recent Developments and Future Plans
2.4 Shukun Technology
2.4.1 Shukun Technology Details
2.4.2 Shukun Technology Major Business
2.4.3 Shukun Technology AI Medical Imaging Software for Lung Diseases Product and Solutions
2.4.4 Shukun Technology AI Medical Imaging Software for Lung Diseases Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Shukun Technology Recent Developments and Future Plans
2.5 Infervision Medical
2.5.1 Infervision Medical Details
2.5.2 Infervision Medical Major Business
2.5.3 Infervision Medical AI Medical Imaging Software for Lung Diseases Product and Solutions
2.5.4 Infervision Medical AI Medical Imaging Software for Lung Diseases Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Infervision Medical Recent Developments and Future Plans
2.6 United-Imaging
2.6.1 United-Imaging Details
2.6.2 United-Imaging Major Business
2.6.3 United-Imaging AI Medical Imaging Software for Lung Diseases Product and Solutions
2.6.4 United-Imaging AI Medical Imaging Software for Lung Diseases Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 United-Imaging Recent Developments and Future Plans
2.7 Yizhun Intelligent
2.7.1 Yizhun Intelligent Details
2.7.2 Yizhun Intelligent Major Business
2.7.3 Yizhun Intelligent AI Medical Imaging Software for Lung Diseases Product and Solutions
2.7.4 Yizhun Intelligent AI Medical Imaging Software for Lung Diseases Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Yizhun Intelligent Recent Developments and Future Plans
2.8 VoxelCloud
2.8.1 VoxelCloud Details
2.8.2 VoxelCloud Major Business
2.8.3 VoxelCloud AI Medical Imaging Software for Lung Diseases Product and Solutions
2.8.4 VoxelCloud AI Medical Imaging Software for Lung Diseases Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 VoxelCloud Recent Developments and Future Plans
2.9 Fosun Aitrox
2.9.1 Fosun Aitrox Details
2.9.2 Fosun Aitrox Major Business
2.9.3 Fosun Aitrox AI Medical Imaging Software for Lung Diseases Product and Solutions
2.9.4 Fosun Aitrox AI Medical Imaging Software for Lung Diseases Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Fosun Aitrox Recent Developments and Future Plans
2.10 Huiying Medical
2.10.1 Huiying Medical Details
2.10.2 Huiying Medical Major Business
2.10.3 Huiying Medical AI Medical Imaging Software for Lung Diseases Product and Solutions
2.10.4 Huiying Medical AI Medical Imaging Software for Lung Diseases Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Huiying Medical Recent Developments and Future Plans
2.11 BioMind
2.11.1 BioMind Details
2.11.2 BioMind Major Business
2.11.3 BioMind AI Medical Imaging Software for Lung Diseases Product and Solutions
2.11.4 BioMind AI Medical Imaging Software for Lung Diseases Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 BioMind Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global AI Medical Imaging Software for Lung Diseases Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of AI Medical Imaging Software for Lung Diseases by Company Revenue
3.2.2 Top 3 AI Medical Imaging Software for Lung Diseases Players Market Share in 2024
3.2.3 Top 6 AI Medical Imaging Software for Lung Diseases Players Market Share in 2024
3.3 AI Medical Imaging Software for Lung Diseases Market: Overall Company Footprint Analysis
3.3.1 AI Medical Imaging Software for Lung Diseases Market: Region Footprint
3.3.2 AI Medical Imaging Software for Lung Diseases Market: Company Product Type Footprint
3.3.3 AI Medical Imaging Software for Lung Diseases Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global AI Medical Imaging Software for Lung Diseases Consumption Value and Market Share by Type (2020-2025)
4.2 Global AI Medical Imaging Software for Lung Diseases Market Forecast by Type (2026-2031)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global AI Medical Imaging Software for Lung Diseases Consumption Value Market Share by Application (2020-2025)
5.2 Global AI Medical Imaging Software for Lung Diseases Market Forecast by Application (2026-2031)
6 NORTH AMERICA
6.1 North America AI Medical Imaging Software for Lung Diseases Consumption Value by Type (2020-2031)
6.2 North America AI Medical Imaging Software for Lung Diseases Market Size by Application (2020-2031)
6.3 North America AI Medical Imaging Software for Lung Diseases Market Size by Country
6.3.1 North America AI Medical Imaging Software for Lung Diseases Consumption Value by Country (2020-2031)
6.3.2 United States AI Medical Imaging Software for Lung Diseases Market Size and Forecast (2020-2031)
6.3.3 Canada AI Medical Imaging Software for Lung Diseases Market Size and Forecast (2020-2031)
6.3.4 Mexico AI Medical Imaging Software for Lung Diseases Market Size and Forecast (2020-2031)
7 EUROPE
7.1 Europe AI Medical Imaging Software for Lung Diseases Consumption Value by Type (2020-2031)
7.2 Europe AI Medical Imaging Software for Lung Diseases Consumption Value by Application (2020-2031)
7.3 Europe AI Medical Imaging Software for Lung Diseases Market Size by Country
7.3.1 Europe AI Medical Imaging Software for Lung Diseases Consumption Value by Country (2020-2031)
7.3.2 Germany AI Medical Imaging Software for Lung Diseases Market Size and Forecast (2020-2031)
7.3.3 France AI Medical Imaging Software for Lung Diseases Market Size and Forecast (2020-2031)
7.3.4 United Kingdom AI Medical Imaging Software for Lung Diseases Market Size and Forecast (2020-2031)
7.3.5 Russia AI Medical Imaging Software for Lung Diseases Market Size and Forecast (2020-2031)
7.3.6 Italy AI Medical Imaging Software for Lung Diseases Market Size and Forecast (2020-2031)
8 ASIA-PACIFIC
8.1 Asia-Pacific AI Medical Imaging Software for Lung Diseases Consumption Value by Type (2020-2031)
8.2 Asia-Pacific AI Medical Imaging Software for Lung Diseases Consumption Value by Application (2020-2031)
8.3 Asia-Pacific AI Medical Imaging Software for Lung Diseases Market Size by Region
8.3.1 Asia-Pacific AI Medical Imaging Software for Lung Diseases Consumption Value by Region (2020-2031)
8.3.2 China AI Medical Imaging Software for Lung Diseases Market Size and Forecast (2020-2031)
8.3.3 Japan AI Medical Imaging Software for Lung Diseases Market Size and Forecast (2020-2031)
8.3.4 South Korea AI Medical Imaging Software for Lung Diseases Market Size and Forecast (2020-2031)
8.3.5 India AI Medical Imaging Software for Lung Diseases Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia AI Medical Imaging Software for Lung Diseases Market Size and Forecast (2020-2031)
8.3.7 Australia AI Medical Imaging Software for Lung Diseases Market Size and Forecast (2020-2031)
9 SOUTH AMERICA
9.1 South America AI Medical Imaging Software for Lung Diseases Consumption Value by Type (2020-2031)
9.2 South America AI Medical Imaging Software for Lung Diseases Consumption Value by Application (2020-2031)
9.3 South America AI Medical Imaging Software for Lung Diseases Market Size by Country
9.3.1 South America AI Medical Imaging Software for Lung Diseases Consumption Value by Country (2020-2031)
9.3.2 Brazil AI Medical Imaging Software for Lung Diseases Market Size and Forecast (2020-2031)
9.3.3 Argentina AI Medical Imaging Software for Lung Diseases Market Size and Forecast (2020-2031)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa AI Medical Imaging Software for Lung Diseases Consumption Value by Type (2020-2031)
10.2 Middle East & Africa AI Medical Imaging Software for Lung Diseases Consumption Value by Application (2020-2031)
10.3 Middle East & Africa AI Medical Imaging Software for Lung Diseases Market Size by Country
10.3.1 Middle East & Africa AI Medical Imaging Software for Lung Diseases Consumption Value by Country (2020-2031)
10.3.2 Turkey AI Medical Imaging Software for Lung Diseases Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia AI Medical Imaging Software for Lung Diseases Market Size and Forecast (2020-2031)
10.3.4 UAE AI Medical Imaging Software for Lung Diseases Market Size and Forecast (2020-2031)
11 MARKET DYNAMICS
11.1 AI Medical Imaging Software for Lung Diseases Market Drivers
11.2 AI Medical Imaging Software for Lung Diseases Market Restraints
11.3 AI Medical Imaging Software for Lung Diseases Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 AI Medical Imaging Software for Lung Diseases Industry Chain
12.2 AI Medical Imaging Software for Lung Diseases Upstream Analysis
12.3 AI Medical Imaging Software for Lung Diseases Midstream Analysis
12.4 AI Medical Imaging Software for Lung Diseases Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global AI Medical Imaging Software for Lung Diseases Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global AI Medical Imaging Software for Lung Diseases Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global AI Medical Imaging Software for Lung Diseases Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global AI Medical Imaging Software for Lung Diseases Consumption Value by Region (2026-2031) & (USD Million)
Table 5. Siemens Company Information, Head Office, and Major Competitors
Table 6. Siemens Major Business
Table 7. Siemens AI Medical Imaging Software for Lung Diseases Product and Solutions
Table 8. Siemens AI Medical Imaging Software for Lung Diseases Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9. Siemens Recent Developments and Future Plans
Table 10. Riverain Technologies Company Information, Head Office, and Major Competitors
Table 11. Riverain Technologies Major Business
Table 12. Riverain Technologies AI Medical Imaging Software for Lung Diseases Product and Solutions
Table 13. Riverain Technologies AI Medical Imaging Software for Lung Diseases Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. Riverain Technologies Recent Developments and Future Plans
Table 15. Deepwise Company Information, Head Office, and Major Competitors
Table 16. Deepwise Major Business
Table 17. Deepwise AI Medical Imaging Software for Lung Diseases Product and Solutions
Table 18. Deepwise AI Medical Imaging Software for Lung Diseases Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. Shukun Technology Company Information, Head Office, and Major Competitors
Table 20. Shukun Technology Major Business
Table 21. Shukun Technology AI Medical Imaging Software for Lung Diseases Product and Solutions
Table 22. Shukun Technology AI Medical Imaging Software for Lung Diseases Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. Shukun Technology Recent Developments and Future Plans
Table 24. Infervision Medical Company Information, Head Office, and Major Competitors
Table 25. Infervision Medical Major Business
Table 26. Infervision Medical AI Medical Imaging Software for Lung Diseases Product and Solutions
Table 27. Infervision Medical AI Medical Imaging Software for Lung Diseases Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. Infervision Medical Recent Developments and Future Plans
Table 29. United-Imaging Company Information, Head Office, and Major Competitors
Table 30. United-Imaging Major Business
Table 31. United-Imaging AI Medical Imaging Software for Lung Diseases Product and Solutions
Table 32. United-Imaging AI Medical Imaging Software for Lung Diseases Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 33. United-Imaging Recent Developments and Future Plans
Table 34. Yizhun Intelligent Company Information, Head Office, and Major Competitors
Table 35. Yizhun Intelligent Major Business
Table 36. Yizhun Intelligent AI Medical Imaging Software for Lung Diseases Product and Solutions
Table 37. Yizhun Intelligent AI Medical Imaging Software for Lung Diseases Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 38. Yizhun Intelligent Recent Developments and Future Plans
Table 39. VoxelCloud Company Information, Head Office, and Major Competitors
Table 40. VoxelCloud Major Business
Table 41. VoxelCloud AI Medical Imaging Software for Lung Diseases Product and Solutions
Table 42. VoxelCloud AI Medical Imaging Software for Lung Diseases Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 43. VoxelCloud Recent Developments and Future Plans
Table 44. Fosun Aitrox Company Information, Head Office, and Major Competitors
Table 45. Fosun Aitrox Major Business
Table 46. Fosun Aitrox AI Medical Imaging Software for Lung Diseases Product and Solutions
Table 47. Fosun Aitrox AI Medical Imaging Software for Lung Diseases Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 48. Fosun Aitrox Recent Developments and Future Plans
Table 49. Huiying Medical Company Information, Head Office, and Major Competitors
Table 50. Huiying Medical Major Business
Table 51. Huiying Medical AI Medical Imaging Software for Lung Diseases Product and Solutions
Table 52. Huiying Medical AI Medical Imaging Software for Lung Diseases Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 53. Huiying Medical Recent Developments and Future Plans
Table 54. BioMind Company Information, Head Office, and Major Competitors
Table 55. BioMind Major Business
Table 56. BioMind AI Medical Imaging Software for Lung Diseases Product and Solutions
Table 57. BioMind AI Medical Imaging Software for Lung Diseases Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 58. BioMind Recent Developments and Future Plans
Table 59. Global AI Medical Imaging Software for Lung Diseases Revenue (USD Million) by Players (2020-2025)
Table 60. Global AI Medical Imaging Software for Lung Diseases Revenue Share by Players (2020-2025)
Table 61. Breakdown of AI Medical Imaging Software for Lung Diseases by Company Type (Tier 1, Tier 2, and Tier 3)
Table 62. Market Position of Players in AI Medical Imaging Software for Lung Diseases, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 63. Head Office of Key AI Medical Imaging Software for Lung Diseases Players
Table 64. AI Medical Imaging Software for Lung Diseases Market: Company Product Type Footprint
Table 65. AI Medical Imaging Software for Lung Diseases Market: Company Product Application Footprint
Table 66. AI Medical Imaging Software for Lung Diseases New Market Entrants and Barriers to Market Entry
Table 67. AI Medical Imaging Software for Lung Diseases Mergers, Acquisition, Agreements, and Collaborations
Table 68. Global AI Medical Imaging Software for Lung Diseases Consumption Value (USD Million) by Type (2020-2025)
Table 69. Global AI Medical Imaging Software for Lung Diseases Consumption Value Share by Type (2020-2025)
Table 70. Global AI Medical Imaging Software for Lung Diseases Consumption Value Forecast by Type (2026-2031)
Table 71. Global AI Medical Imaging Software for Lung Diseases Consumption Value by Application (2020-2025)
Table 72. Global AI Medical Imaging Software for Lung Diseases Consumption Value Forecast by Application (2026-2031)
Table 73. North America AI Medical Imaging Software for Lung Diseases Consumption Value by Type (2020-2025) & (USD Million)
Table 74. North America AI Medical Imaging Software for Lung Diseases Consumption Value by Type (2026-2031) & (USD Million)
Table 75. North America AI Medical Imaging Software for Lung Diseases Consumption Value by Application (2020-2025) & (USD Million)
Table 76. North America AI Medical Imaging Software for Lung Diseases Consumption Value by Application (2026-2031) & (USD Million)
Table 77. North America AI Medical Imaging Software for Lung Diseases Consumption Value by Country (2020-2025) & (USD Million)
Table 78. North America AI Medical Imaging Software for Lung Diseases Consumption Value by Country (2026-2031) & (USD Million)
Table 79. Europe AI Medical Imaging Software for Lung Diseases Consumption Value by Type (2020-2025) & (USD Million)
Table 80. Europe AI Medical Imaging Software for Lung Diseases Consumption Value by Type (2026-2031) & (USD Million)
Table 81. Europe AI Medical Imaging Software for Lung Diseases Consumption Value by Application (2020-2025) & (USD Million)
Table 82. Europe AI Medical Imaging Software for Lung Diseases Consumption Value by Application (2026-2031) & (USD Million)
Table 83. Europe AI Medical Imaging Software for Lung Diseases Consumption Value by Country (2020-2025) & (USD Million)
Table 84. Europe AI Medical Imaging Software for Lung Diseases Consumption Value by Country (2026-2031) & (USD Million)
Table 85. Asia-Pacific AI Medical Imaging Software for Lung Diseases Consumption Value by Type (2020-2025) & (USD Million)
Table 86. Asia-Pacific AI Medical Imaging Software for Lung Diseases Consumption Value by Type (2026-2031) & (USD Million)
Table 87. Asia-Pacific AI Medical Imaging Software for Lung Diseases Consumption Value by Application (2020-2025) & (USD Million)
Table 88. Asia-Pacific AI Medical Imaging Software for Lung Diseases Consumption Value by Application (2026-2031) & (USD Million)
Table 89. Asia-Pacific AI Medical Imaging Software for Lung Diseases Consumption Value by Region (2020-2025) & (USD Million)
Table 90. Asia-Pacific AI Medical Imaging Software for Lung Diseases Consumption Value by Region (2026-2031) & (USD Million)
Table 91. South America AI Medical Imaging Software for Lung Diseases Consumption Value by Type (2020-2025) & (USD Million)
Table 92. South America AI Medical Imaging Software for Lung Diseases Consumption Value by Type (2026-2031) & (USD Million)
Table 93. South America AI Medical Imaging Software for Lung Diseases Consumption Value by Application (2020-2025) & (USD Million)
Table 94. South America AI Medical Imaging Software for Lung Diseases Consumption Value by Application (2026-2031) & (USD Million)
Table 95. South America AI Medical Imaging Software for Lung Diseases Consumption Value by Country (2020-2025) & (USD Million)
Table 96. South America AI Medical Imaging Software for Lung Diseases Consumption Value by Country (2026-2031) & (USD Million)
Table 97. Middle East & Africa AI Medical Imaging Software for Lung Diseases Consumption Value by Type (2020-2025) & (USD Million)
Table 98. Middle East & Africa AI Medical Imaging Software for Lung Diseases Consumption Value by Type (2026-2031) & (USD Million)
Table 99. Middle East & Africa AI Medical Imaging Software for Lung Diseases Consumption Value by Application (2020-2025) & (USD Million)
Table 100. Middle East & Africa AI Medical Imaging Software for Lung Diseases Consumption Value by Application (2026-2031) & (USD Million)
Table 101. Middle East & Africa AI Medical Imaging Software for Lung Diseases Consumption Value by Country (2020-2025) & (USD Million)
Table 102. Middle East & Africa AI Medical Imaging Software for Lung Diseases Consumption Value by Country (2026-2031) & (USD Million)
Table 103. Global Key Players of AI Medical Imaging Software for Lung Diseases Upstream (Raw Materials)
Table 104. Global AI Medical Imaging Software for Lung Diseases Typical Customers
Table 1. Global AI Medical Imaging Software for Lung Diseases Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global AI Medical Imaging Software for Lung Diseases Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global AI Medical Imaging Software for Lung Diseases Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global AI Medical Imaging Software for Lung Diseases Consumption Value by Region (2026-2031) & (USD Million)
Table 5. Siemens Company Information, Head Office, and Major Competitors
Table 6. Siemens Major Business
Table 7. Siemens AI Medical Imaging Software for Lung Diseases Product and Solutions
Table 8. Siemens AI Medical Imaging Software for Lung Diseases Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9. Siemens Recent Developments and Future Plans
Table 10. Riverain Technologies Company Information, Head Office, and Major Competitors
Table 11. Riverain Technologies Major Business
Table 12. Riverain Technologies AI Medical Imaging Software for Lung Diseases Product and Solutions
Table 13. Riverain Technologies AI Medical Imaging Software for Lung Diseases Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. Riverain Technologies Recent Developments and Future Plans
Table 15. Deepwise Company Information, Head Office, and Major Competitors
Table 16. Deepwise Major Business
Table 17. Deepwise AI Medical Imaging Software for Lung Diseases Product and Solutions
Table 18. Deepwise AI Medical Imaging Software for Lung Diseases Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. Shukun Technology Company Information, Head Office, and Major Competitors
Table 20. Shukun Technology Major Business
Table 21. Shukun Technology AI Medical Imaging Software for Lung Diseases Product and Solutions
Table 22. Shukun Technology AI Medical Imaging Software for Lung Diseases Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. Shukun Technology Recent Developments and Future Plans
Table 24. Infervision Medical Company Information, Head Office, and Major Competitors
Table 25. Infervision Medical Major Business
Table 26. Infervision Medical AI Medical Imaging Software for Lung Diseases Product and Solutions
Table 27. Infervision Medical AI Medical Imaging Software for Lung Diseases Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. Infervision Medical Recent Developments and Future Plans
Table 29. United-Imaging Company Information, Head Office, and Major Competitors
Table 30. United-Imaging Major Business
Table 31. United-Imaging AI Medical Imaging Software for Lung Diseases Product and Solutions
Table 32. United-Imaging AI Medical Imaging Software for Lung Diseases Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 33. United-Imaging Recent Developments and Future Plans
Table 34. Yizhun Intelligent Company Information, Head Office, and Major Competitors
Table 35. Yizhun Intelligent Major Business
Table 36. Yizhun Intelligent AI Medical Imaging Software for Lung Diseases Product and Solutions
Table 37. Yizhun Intelligent AI Medical Imaging Software for Lung Diseases Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 38. Yizhun Intelligent Recent Developments and Future Plans
Table 39. VoxelCloud Company Information, Head Office, and Major Competitors
Table 40. VoxelCloud Major Business
Table 41. VoxelCloud AI Medical Imaging Software for Lung Diseases Product and Solutions
Table 42. VoxelCloud AI Medical Imaging Software for Lung Diseases Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 43. VoxelCloud Recent Developments and Future Plans
Table 44. Fosun Aitrox Company Information, Head Office, and Major Competitors
Table 45. Fosun Aitrox Major Business
Table 46. Fosun Aitrox AI Medical Imaging Software for Lung Diseases Product and Solutions
Table 47. Fosun Aitrox AI Medical Imaging Software for Lung Diseases Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 48. Fosun Aitrox Recent Developments and Future Plans
Table 49. Huiying Medical Company Information, Head Office, and Major Competitors
Table 50. Huiying Medical Major Business
Table 51. Huiying Medical AI Medical Imaging Software for Lung Diseases Product and Solutions
Table 52. Huiying Medical AI Medical Imaging Software for Lung Diseases Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 53. Huiying Medical Recent Developments and Future Plans
Table 54. BioMind Company Information, Head Office, and Major Competitors
Table 55. BioMind Major Business
Table 56. BioMind AI Medical Imaging Software for Lung Diseases Product and Solutions
Table 57. BioMind AI Medical Imaging Software for Lung Diseases Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 58. BioMind Recent Developments and Future Plans
Table 59. Global AI Medical Imaging Software for Lung Diseases Revenue (USD Million) by Players (2020-2025)
Table 60. Global AI Medical Imaging Software for Lung Diseases Revenue Share by Players (2020-2025)
Table 61. Breakdown of AI Medical Imaging Software for Lung Diseases by Company Type (Tier 1, Tier 2, and Tier 3)
Table 62. Market Position of Players in AI Medical Imaging Software for Lung Diseases, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 63. Head Office of Key AI Medical Imaging Software for Lung Diseases Players
Table 64. AI Medical Imaging Software for Lung Diseases Market: Company Product Type Footprint
Table 65. AI Medical Imaging Software for Lung Diseases Market: Company Product Application Footprint
Table 66. AI Medical Imaging Software for Lung Diseases New Market Entrants and Barriers to Market Entry
Table 67. AI Medical Imaging Software for Lung Diseases Mergers, Acquisition, Agreements, and Collaborations
Table 68. Global AI Medical Imaging Software for Lung Diseases Consumption Value (USD Million) by Type (2020-2025)
Table 69. Global AI Medical Imaging Software for Lung Diseases Consumption Value Share by Type (2020-2025)
Table 70. Global AI Medical Imaging Software for Lung Diseases Consumption Value Forecast by Type (2026-2031)
Table 71. Global AI Medical Imaging Software for Lung Diseases Consumption Value by Application (2020-2025)
Table 72. Global AI Medical Imaging Software for Lung Diseases Consumption Value Forecast by Application (2026-2031)
Table 73. North America AI Medical Imaging Software for Lung Diseases Consumption Value by Type (2020-2025) & (USD Million)
Table 74. North America AI Medical Imaging Software for Lung Diseases Consumption Value by Type (2026-2031) & (USD Million)
Table 75. North America AI Medical Imaging Software for Lung Diseases Consumption Value by Application (2020-2025) & (USD Million)
Table 76. North America AI Medical Imaging Software for Lung Diseases Consumption Value by Application (2026-2031) & (USD Million)
Table 77. North America AI Medical Imaging Software for Lung Diseases Consumption Value by Country (2020-2025) & (USD Million)
Table 78. North America AI Medical Imaging Software for Lung Diseases Consumption Value by Country (2026-2031) & (USD Million)
Table 79. Europe AI Medical Imaging Software for Lung Diseases Consumption Value by Type (2020-2025) & (USD Million)
Table 80. Europe AI Medical Imaging Software for Lung Diseases Consumption Value by Type (2026-2031) & (USD Million)
Table 81. Europe AI Medical Imaging Software for Lung Diseases Consumption Value by Application (2020-2025) & (USD Million)
Table 82. Europe AI Medical Imaging Software for Lung Diseases Consumption Value by Application (2026-2031) & (USD Million)
Table 83. Europe AI Medical Imaging Software for Lung Diseases Consumption Value by Country (2020-2025) & (USD Million)
Table 84. Europe AI Medical Imaging Software for Lung Diseases Consumption Value by Country (2026-2031) & (USD Million)
Table 85. Asia-Pacific AI Medical Imaging Software for Lung Diseases Consumption Value by Type (2020-2025) & (USD Million)
Table 86. Asia-Pacific AI Medical Imaging Software for Lung Diseases Consumption Value by Type (2026-2031) & (USD Million)
Table 87. Asia-Pacific AI Medical Imaging Software for Lung Diseases Consumption Value by Application (2020-2025) & (USD Million)
Table 88. Asia-Pacific AI Medical Imaging Software for Lung Diseases Consumption Value by Application (2026-2031) & (USD Million)
Table 89. Asia-Pacific AI Medical Imaging Software for Lung Diseases Consumption Value by Region (2020-2025) & (USD Million)
Table 90. Asia-Pacific AI Medical Imaging Software for Lung Diseases Consumption Value by Region (2026-2031) & (USD Million)
Table 91. South America AI Medical Imaging Software for Lung Diseases Consumption Value by Type (2020-2025) & (USD Million)
Table 92. South America AI Medical Imaging Software for Lung Diseases Consumption Value by Type (2026-2031) & (USD Million)
Table 93. South America AI Medical Imaging Software for Lung Diseases Consumption Value by Application (2020-2025) & (USD Million)
Table 94. South America AI Medical Imaging Software for Lung Diseases Consumption Value by Application (2026-2031) & (USD Million)
Table 95. South America AI Medical Imaging Software for Lung Diseases Consumption Value by Country (2020-2025) & (USD Million)
Table 96. South America AI Medical Imaging Software for Lung Diseases Consumption Value by Country (2026-2031) & (USD Million)
Table 97. Middle East & Africa AI Medical Imaging Software for Lung Diseases Consumption Value by Type (2020-2025) & (USD Million)
Table 98. Middle East & Africa AI Medical Imaging Software for Lung Diseases Consumption Value by Type (2026-2031) & (USD Million)
Table 99. Middle East & Africa AI Medical Imaging Software for Lung Diseases Consumption Value by Application (2020-2025) & (USD Million)
Table 100. Middle East & Africa AI Medical Imaging Software for Lung Diseases Consumption Value by Application (2026-2031) & (USD Million)
Table 101. Middle East & Africa AI Medical Imaging Software for Lung Diseases Consumption Value by Country (2020-2025) & (USD Million)
Table 102. Middle East & Africa AI Medical Imaging Software for Lung Diseases Consumption Value by Country (2026-2031) & (USD Million)
Table 103. Global Key Players of AI Medical Imaging Software for Lung Diseases Upstream (Raw Materials)
Table 104. Global AI Medical Imaging Software for Lung Diseases Typical Customers
LIST OF FIGURES
Figure 1. AI Medical Imaging Software for Lung Diseases Picture
Figure 2. Global AI Medical Imaging Software for Lung Diseases Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global AI Medical Imaging Software for Lung Diseases Consumption Value Market Share by Type in 2024
Figure 4. Pulmonary Nodules
Figure 5. Pneumonia
Figure 6. Other
Figure 7. Global AI Medical Imaging Software for Lung Diseases Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 8. AI Medical Imaging Software for Lung Diseases Consumption Value Market Share by Application in 2024
Figure 9. Hospital Picture
Figure 10. Clinic Picture
Figure 11. Global AI Medical Imaging Software for Lung Diseases Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 12. Global AI Medical Imaging Software for Lung Diseases Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 13. Global Market AI Medical Imaging Software for Lung Diseases Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 14. Global AI Medical Imaging Software for Lung Diseases Consumption Value Market Share by Region (2020-2031)
Figure 15. Global AI Medical Imaging Software for Lung Diseases Consumption Value Market Share by Region in 2024
Figure 16. North America AI Medical Imaging Software for Lung Diseases Consumption Value (2020-2031) & (USD Million)
Figure 17. Europe AI Medical Imaging Software for Lung Diseases Consumption Value (2020-2031) & (USD Million)
Figure 18. Asia-Pacific AI Medical Imaging Software for Lung Diseases Consumption Value (2020-2031) & (USD Million)
Figure 19. South America AI Medical Imaging Software for Lung Diseases Consumption Value (2020-2031) & (USD Million)
Figure 20. Middle East & Africa AI Medical Imaging Software for Lung Diseases Consumption Value (2020-2031) & (USD Million)
Figure 21. Company Three Recent Developments and Future Plans
Figure 22. Global AI Medical Imaging Software for Lung Diseases Revenue Share by Players in 2024
Figure 23. AI Medical Imaging Software for Lung Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
Figure 24. Market Share of AI Medical Imaging Software for Lung Diseases by Player Revenue in 2024
Figure 25. Top 3 AI Medical Imaging Software for Lung Diseases Players Market Share in 2024
Figure 26. Top 6 AI Medical Imaging Software for Lung Diseases Players Market Share in 2024
Figure 27. Global AI Medical Imaging Software for Lung Diseases Consumption Value Share by Type (2020-2025)
Figure 28. Global AI Medical Imaging Software for Lung Diseases Market Share Forecast by Type (2026-2031)
Figure 29. Global AI Medical Imaging Software for Lung Diseases Consumption Value Share by Application (2020-2025)
Figure 30. Global AI Medical Imaging Software for Lung Diseases Market Share Forecast by Application (2026-2031)
Figure 31. North America AI Medical Imaging Software for Lung Diseases Consumption Value Market Share by Type (2020-2031)
Figure 32. North America AI Medical Imaging Software for Lung Diseases Consumption Value Market Share by Application (2020-2031)
Figure 33. North America AI Medical Imaging Software for Lung Diseases Consumption Value Market Share by Country (2020-2031)
Figure 34. United States AI Medical Imaging Software for Lung Diseases Consumption Value (2020-2031) & (USD Million)
Figure 35. Canada AI Medical Imaging Software for Lung Diseases Consumption Value (2020-2031) & (USD Million)
Figure 36. Mexico AI Medical Imaging Software for Lung Diseases Consumption Value (2020-2031) & (USD Million)
Figure 37. Europe AI Medical Imaging Software for Lung Diseases Consumption Value Market Share by Type (2020-2031)
Figure 38. Europe AI Medical Imaging Software for Lung Diseases Consumption Value Market Share by Application (2020-2031)
Figure 39. Europe AI Medical Imaging Software for Lung Diseases Consumption Value Market Share by Country (2020-2031)
Figure 40. Germany AI Medical Imaging Software for Lung Diseases Consumption Value (2020-2031) & (USD Million)
Figure 41. France AI Medical Imaging Software for Lung Diseases Consumption Value (2020-2031) & (USD Million)
Figure 42. United Kingdom AI Medical Imaging Software for Lung Diseases Consumption Value (2020-2031) & (USD Million)
Figure 43. Russia AI Medical Imaging Software for Lung Diseases Consumption Value (2020-2031) & (USD Million)
Figure 44. Italy AI Medical Imaging Software for Lung Diseases Consumption Value (2020-2031) & (USD Million)
Figure 45. Asia-Pacific AI Medical Imaging Software for Lung Diseases Consumption Value Market Share by Type (2020-2031)
Figure 46. Asia-Pacific AI Medical Imaging Software for Lung Diseases Consumption Value Market Share by Application (2020-2031)
Figure 47. Asia-Pacific AI Medical Imaging Software for Lung Diseases Consumption Value Market Share by Region (2020-2031)
Figure 48. China AI Medical Imaging Software for Lung Diseases Consumption Value (2020-2031) & (USD Million)
Figure 49. Japan AI Medical Imaging Software for Lung Diseases Consumption Value (2020-2031) & (USD Million)
Figure 50. South Korea AI Medical Imaging Software for Lung Diseases Consumption Value (2020-2031) & (USD Million)
Figure 51. India AI Medical Imaging Software for Lung Diseases Consumption Value (2020-2031) & (USD Million)
Figure 52. Southeast Asia AI Medical Imaging Software for Lung Diseases Consumption Value (2020-2031) & (USD Million)
Figure 53. Australia AI Medical Imaging Software for Lung Diseases Consumption Value (2020-2031) & (USD Million)
Figure 54. South America AI Medical Imaging Software for Lung Diseases Consumption Value Market Share by Type (2020-2031)
Figure 55. South America AI Medical Imaging Software for Lung Diseases Consumption Value Market Share by Application (2020-2031)
Figure 56. South America AI Medical Imaging Software for Lung Diseases Consumption Value Market Share by Country (2020-2031)
Figure 57. Brazil AI Medical Imaging Software for Lung Diseases Consumption Value (2020-2031) & (USD Million)
Figure 58. Argentina AI Medical Imaging Software for Lung Diseases Consumption Value (2020-2031) & (USD Million)
Figure 59. Middle East & Africa AI Medical Imaging Software for Lung Diseases Consumption Value Market Share by Type (2020-2031)
Figure 60. Middle East & Africa AI Medical Imaging Software for Lung Diseases Consumption Value Market Share by Application (2020-2031)
Figure 61. Middle East & Africa AI Medical Imaging Software for Lung Diseases Consumption Value Market Share by Country (2020-2031)
Figure 62. Turkey AI Medical Imaging Software for Lung Diseases Consumption Value (2020-2031) & (USD Million)
Figure 63. Saudi Arabia AI Medical Imaging Software for Lung Diseases Consumption Value (2020-2031) & (USD Million)
Figure 64. UAE AI Medical Imaging Software for Lung Diseases Consumption Value (2020-2031) & (USD Million)
Figure 65. AI Medical Imaging Software for Lung Diseases Market Drivers
Figure 66. AI Medical Imaging Software for Lung Diseases Market Restraints
Figure 67. AI Medical Imaging Software for Lung Diseases Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. AI Medical Imaging Software for Lung Diseases Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
Figure 1. AI Medical Imaging Software for Lung Diseases Picture
Figure 2. Global AI Medical Imaging Software for Lung Diseases Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global AI Medical Imaging Software for Lung Diseases Consumption Value Market Share by Type in 2024
Figure 4. Pulmonary Nodules
Figure 5. Pneumonia
Figure 6. Other
Figure 7. Global AI Medical Imaging Software for Lung Diseases Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 8. AI Medical Imaging Software for Lung Diseases Consumption Value Market Share by Application in 2024
Figure 9. Hospital Picture
Figure 10. Clinic Picture
Figure 11. Global AI Medical Imaging Software for Lung Diseases Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 12. Global AI Medical Imaging Software for Lung Diseases Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 13. Global Market AI Medical Imaging Software for Lung Diseases Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 14. Global AI Medical Imaging Software for Lung Diseases Consumption Value Market Share by Region (2020-2031)
Figure 15. Global AI Medical Imaging Software for Lung Diseases Consumption Value Market Share by Region in 2024
Figure 16. North America AI Medical Imaging Software for Lung Diseases Consumption Value (2020-2031) & (USD Million)
Figure 17. Europe AI Medical Imaging Software for Lung Diseases Consumption Value (2020-2031) & (USD Million)
Figure 18. Asia-Pacific AI Medical Imaging Software for Lung Diseases Consumption Value (2020-2031) & (USD Million)
Figure 19. South America AI Medical Imaging Software for Lung Diseases Consumption Value (2020-2031) & (USD Million)
Figure 20. Middle East & Africa AI Medical Imaging Software for Lung Diseases Consumption Value (2020-2031) & (USD Million)
Figure 21. Company Three Recent Developments and Future Plans
Figure 22. Global AI Medical Imaging Software for Lung Diseases Revenue Share by Players in 2024
Figure 23. AI Medical Imaging Software for Lung Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
Figure 24. Market Share of AI Medical Imaging Software for Lung Diseases by Player Revenue in 2024
Figure 25. Top 3 AI Medical Imaging Software for Lung Diseases Players Market Share in 2024
Figure 26. Top 6 AI Medical Imaging Software for Lung Diseases Players Market Share in 2024
Figure 27. Global AI Medical Imaging Software for Lung Diseases Consumption Value Share by Type (2020-2025)
Figure 28. Global AI Medical Imaging Software for Lung Diseases Market Share Forecast by Type (2026-2031)
Figure 29. Global AI Medical Imaging Software for Lung Diseases Consumption Value Share by Application (2020-2025)
Figure 30. Global AI Medical Imaging Software for Lung Diseases Market Share Forecast by Application (2026-2031)
Figure 31. North America AI Medical Imaging Software for Lung Diseases Consumption Value Market Share by Type (2020-2031)
Figure 32. North America AI Medical Imaging Software for Lung Diseases Consumption Value Market Share by Application (2020-2031)
Figure 33. North America AI Medical Imaging Software for Lung Diseases Consumption Value Market Share by Country (2020-2031)
Figure 34. United States AI Medical Imaging Software for Lung Diseases Consumption Value (2020-2031) & (USD Million)
Figure 35. Canada AI Medical Imaging Software for Lung Diseases Consumption Value (2020-2031) & (USD Million)
Figure 36. Mexico AI Medical Imaging Software for Lung Diseases Consumption Value (2020-2031) & (USD Million)
Figure 37. Europe AI Medical Imaging Software for Lung Diseases Consumption Value Market Share by Type (2020-2031)
Figure 38. Europe AI Medical Imaging Software for Lung Diseases Consumption Value Market Share by Application (2020-2031)
Figure 39. Europe AI Medical Imaging Software for Lung Diseases Consumption Value Market Share by Country (2020-2031)
Figure 40. Germany AI Medical Imaging Software for Lung Diseases Consumption Value (2020-2031) & (USD Million)
Figure 41. France AI Medical Imaging Software for Lung Diseases Consumption Value (2020-2031) & (USD Million)
Figure 42. United Kingdom AI Medical Imaging Software for Lung Diseases Consumption Value (2020-2031) & (USD Million)
Figure 43. Russia AI Medical Imaging Software for Lung Diseases Consumption Value (2020-2031) & (USD Million)
Figure 44. Italy AI Medical Imaging Software for Lung Diseases Consumption Value (2020-2031) & (USD Million)
Figure 45. Asia-Pacific AI Medical Imaging Software for Lung Diseases Consumption Value Market Share by Type (2020-2031)
Figure 46. Asia-Pacific AI Medical Imaging Software for Lung Diseases Consumption Value Market Share by Application (2020-2031)
Figure 47. Asia-Pacific AI Medical Imaging Software for Lung Diseases Consumption Value Market Share by Region (2020-2031)
Figure 48. China AI Medical Imaging Software for Lung Diseases Consumption Value (2020-2031) & (USD Million)
Figure 49. Japan AI Medical Imaging Software for Lung Diseases Consumption Value (2020-2031) & (USD Million)
Figure 50. South Korea AI Medical Imaging Software for Lung Diseases Consumption Value (2020-2031) & (USD Million)
Figure 51. India AI Medical Imaging Software for Lung Diseases Consumption Value (2020-2031) & (USD Million)
Figure 52. Southeast Asia AI Medical Imaging Software for Lung Diseases Consumption Value (2020-2031) & (USD Million)
Figure 53. Australia AI Medical Imaging Software for Lung Diseases Consumption Value (2020-2031) & (USD Million)
Figure 54. South America AI Medical Imaging Software for Lung Diseases Consumption Value Market Share by Type (2020-2031)
Figure 55. South America AI Medical Imaging Software for Lung Diseases Consumption Value Market Share by Application (2020-2031)
Figure 56. South America AI Medical Imaging Software for Lung Diseases Consumption Value Market Share by Country (2020-2031)
Figure 57. Brazil AI Medical Imaging Software for Lung Diseases Consumption Value (2020-2031) & (USD Million)
Figure 58. Argentina AI Medical Imaging Software for Lung Diseases Consumption Value (2020-2031) & (USD Million)
Figure 59. Middle East & Africa AI Medical Imaging Software for Lung Diseases Consumption Value Market Share by Type (2020-2031)
Figure 60. Middle East & Africa AI Medical Imaging Software for Lung Diseases Consumption Value Market Share by Application (2020-2031)
Figure 61. Middle East & Africa AI Medical Imaging Software for Lung Diseases Consumption Value Market Share by Country (2020-2031)
Figure 62. Turkey AI Medical Imaging Software for Lung Diseases Consumption Value (2020-2031) & (USD Million)
Figure 63. Saudi Arabia AI Medical Imaging Software for Lung Diseases Consumption Value (2020-2031) & (USD Million)
Figure 64. UAE AI Medical Imaging Software for Lung Diseases Consumption Value (2020-2031) & (USD Million)
Figure 65. AI Medical Imaging Software for Lung Diseases Market Drivers
Figure 66. AI Medical Imaging Software for Lung Diseases Market Restraints
Figure 67. AI Medical Imaging Software for Lung Diseases Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. AI Medical Imaging Software for Lung Diseases Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
